A new analysis suggests HIV impairs the immune system's ability to recognize tumor neoantigens in non-small cell lung cancer ...

The European Respiratory Society’s annual Congress (ERS Congress) took place in Barcelona, Spain, in September 2026. During ...

Founder Patrick Soon-Shiong outlined an ‘Immunotherapy 2.0’ approach aimed at strengthening immune defenses and preventing ...

Machine-learning models combining clinical data and chest CT report features can probabilistically classify lung cancer subtypes in patients presenting with synchronous brain metastases, potentially ...

Mizuho Securities maintained a Buy rating and a USD 12.00 price target for Immuneering stock on October 2, 2026, according to ...

Heritage Hunters to host Genealogy Workshop Oct. 10 The Hamilton Heritage Hunters Genealogical Society will hold a genealogy workshop on Saturday, Oct. 10. This will be held at the Jane Young House, ...

CSPCPharma (01093) announced that the Group will present eight latest clinical trial updates at the European Society for ...

The 7th Annual Emirates Oncology Society Conference has recommended expanding the use of artificial intelligence to predict ...

The Strasbourg-based biotech company indicated, in a press release published on October 5, 2026, that it will exhibit preclinical data on a chimeric oncolytic poxvirus designed for systemic ...

Global Antibody Drug Conjugates CDMO Market was valued at USD 10.24 Billion in 2025 and is expected to grow at 11.62% CAGR to reach USD 30.74 Billion by 2035.

Outcomes have improved drastically in the United States for some forms of the disease, but those for others continue to lag.

Iovance raised 2026 revenue guidance as Amtagvi adoption accelerates with broader access, physician awareness, and faster ...